A proof-of-concept study supports the safety and efficacy of rezpegaldesleukin vs placebo for treating severe-to-very-severe alopecia areata.
Damian McNamara is a journalist at Medscape Medical News and MDedge. He specializes in medicine and healthcare, covering a range of topics including dermatology, endocrinology, immunotherapy, oncology, and remote healthcare. Damian's work has been featured in WebMD, Medscape, MDedge, and the University of Miami.




